arrow
Y

Yongkun Wei

3201 hospital
H指数:49
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Effects of early photobiomodulation therapy on motor recovery in patients with incomplete acute cervical spinal cord injury: A multicenter randomized controlled trial” [J Orthop Transl 2026 Jan 14:56:101040]

更正“早期光生物调节疗法对不完全急性颈椎脊髓损伤患者运动恢复的影响:一项多中心随机对照试验”[J Orthop Transl 2026 Jan 14:56:101040]

2026-09-190
OA
From algorithm to verification: based on network toxicology and machine learning; the immunomodulatory role of IGFBP1/MKI67/C9 in perfluorooctanoic acid-induced osteoarthritis was discovered; and a diagnostic model was constructed

从算法到验证:基于网络毒理学和机器学习;发现IGFBP1/MKI67/C9在过氧代辛酸诱导的骨关节炎中的免疫调节作用;并构建了诊断模型

2026-05-280
OAAI
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer

全反式视黄酸通过视黄酰化介导的USP7解离破坏ADAR1蛋白稳定性,并改善胰腺癌的免疫治疗

2026-05-110
OAAI
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function

EZH2的AMPK磷酸化抑制PRC2甲基转移酶活性和致癌功能

2025-08-130
PRE
Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

针对syndecan-1轴的治疗性靶向克服了胃肠道癌症中针对KRAS疗法的获得性耐药。

2025-07-250
OAAI
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function

EZH2的磷酸化由AMPK介导,抑制了PRC2甲基转移酶活性和致癌功能。

2025-07-230
PRE
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer

靶向化疗诱导的适应性信号传导回路赋予胰腺癌治疗脆弱性

2024-10-290
OAAI
Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition

星形胶质细胞诱导的Cdk5通过抑制mhc-i表达逃避免疫识别促进乳腺癌脑转移

2024-09-201
PRE
Blockade of CD24 sensitizes pancreatic cancer to Kras inhibitors
2024-03-220
PRE
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
2022-10-1713
OAAI
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation
2021-05-1320
OAAI